Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026. However, the value of ...

Intuitive Surgical (ISRG) leads robotic surgery with sticky recurring revenue, but valuation is rich after a 26% YTD drop.

On Tuesday, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories. The ...

Intuitive Surgical falls 11% in a month despite strong revenues, procedure growth and da Vinci 5 adoption, raising questions ...

The robotic-surgery leader has lost nearly a third of its value since January. Here's what's weighing on the stock.

Intuitive Surgical, maker of the da Vinci and Ion systems, beat third-quarter profit and sales forecasts. That lifted the shares into the plus column for 2025. The company is "in the driver’s seat" of ...

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Our technologies include the da Vinci ...

Patton’s promotion comes as competition in robotic surgery intensifies, and Intuitive looks to expand its global commercial operations to meet anticipated growth.

The surgical robotics company's procedure growth remained impressive, supporting recurring revenue. Intuitive Surgical's Da Vinci 5 adoption is ramping quickly. Sales of Ion are growing faster than ...

2026 hasn't been a happy New Year so far for Intuitive Surgical (NASDAQ: ISRG) shareholders. The robotic surgical systems stock is in negative territory. And Intuitive's latest quarterly results ...